Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
Bruno O. Villoutreix, Philippe Beaune, Ryad Tamouza, Rajagopal Krishnamoorthy, Marion Leboyer
Topics & Concepts
Drug repositioningRepurposingCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DrugMedicinePharmacologyDrug discoveryPsychiatryVirologyBioinformaticsBiologyInternal medicineInfectious disease (medical specialty)OutbreakEcologyDiseaseTryptophan and brain disordersPharmacological Receptor Mechanisms and EffectsCOVID-19 Clinical Research Studies